Abstract: Provided is a molten material treatment apparatus including: a container having an upper portion, on which a molten material injection part is disposed, and a bottom part in which a hole is formed; a gas injection part attached to the bottom part between the molten material injection part and the hole; a chamber part formed on the upper portion of the container so as to face the gas injection part and having an inside open downward; and a plurality of vertical members disposed so as to cross a plurality of positions of a rotary flow region formed between the chamber part and the bottom part, wherein an inclusion removal efficiency can be improved while maintaining the molten material surface by a method in which a plurality of mutually different rotary flows are generated in a plurality of sections within the rotary flow region and are partially overlapped.

Abstract: Disclosed is a touch sensitive display apparatus which decreases a load of each of a plurality of touch electrodes and reduces a load deviation between the plurality of touch electrodes, thereby enhancing image quality. The touch sensitive display apparatus comprises a touch sensitive panel. The touch panel comprises a plurality of touch electrodes comprising at least a first touch electrode. The first touch electrode comprises a plurality of first touch electrode lines that are parallel to each other. A first touch signal line is connected to the plurality of first touch electrode lines of the first touch electrode, and the first touch electrode is driven for image display and touch sensing via the first touch signal line. A first connecting line is in a different layer than the first touch electrode lines, and the first connecting line is connected to the plurality of first touch electrode lines.

Abstract: The present invention relates to a method and a system for selecting an anticancer agent based on protein damage information of an individual by using individual genome sequencing. The method and the system, according to the present invention, are highly reliable and widely applicable techniques capable of predicting side effects or risks of specific drugs, in other words, anticancer agents, for each individual by performing sequence analysis of an exon part of a gene that codes various proteins involved in pharmacokinetics or pharmacodynamics of anticancer agents.

Abstract: The present invention relates to a fluorescent nanodiamond preparing method including a first operation of preparing nanodiamonds having an average particle diameter of 10 nm or less, a second operation of implanting plasma ions into the nanodiamonds, a third operation of heat-treating the nanodiamonds implanted with the plasma ions under a vacuum or inert gas atmosphere, a fourth operation of oxygen treatment of the heat-treated nanodiamonds under a gas atmosphere including oxygen to oxidize the surfaces of the nanodiamonds, a fifth operation of acid-treating the oxygen-treated nanodiamonds, a sixth operation of centrifuging and cleaning the acid-treated nanodiamonds, and a seventh operation of drying the cleaned nanodiamonds, wherein, in the second operation, the plasma ions are implanted at an incident ion dose of 1013 ions/cm2 or more and 1020 ions/cm2 or less.

Abstract: Sound output devices, output systems and methods are provided. The sound output device includes a speaker; a communicator configured to perform communication with an external speaker and a content source that provides sound content to the external speaker; and a processor configured to recognize the external speaker in response to the device entering into a predetermined range from the external speaker, to perform pairing with the external speaker, to receive information about the content source from the external speaker, to receive the sound content from the content source based on the information about the content source, and to output the received sound content through the speaker.

Abstract: A fuel cell having a structure for detachably mounting a cell-monitoring connector thereon includes separators arranged to be spaced apart from each other in a first direction, each of the separators including a receiving recess arranged in one side thereof, and hook-shaped gaskets respectively disposed on the separators and located around the receiving recess. The cell-monitoring connector includes a housing, at least a portion of the housing being received in a receiving space defined by the receiving recess, and connection terminals inserted into the housing to be connected to the separators. The housing includes a body inserted into the receiving space in a second direction that intersects the first direction, and a lever portion including a latching protrusion configured to be latched to or separated from a corresponding gasket among the hook-shaped gaskets by a pressing operation.

Abstract: The present disclosure relates to a catalyst for direct nonoxidative conversion of methane and a method of preparing the same, and more particularly to a method of preparing a catalyst for direct nonoxidative conversion of methane, in which a catalyst optimized for the direct conversion reaction of methane can be easily prepared without precise control of the reaction conditions for direct conversion of methane, thereby simultaneously maximizing the catalytic reaction rate and minimizing coke formation, and exhibiting stable catalytic performance even after long-term operation, and to a catalyst for direct nonoxidative conversion of methane prepared using the above method.

Abstract: The present invention relates to a carbon nanotube fiber and methods for preparing the same. In one embodiment, a method for preparing a carbon nanotube fiber comprises reacting a carbon source in the presence of a catalyst and a catalytic activator to form carbon nanotube aggregates, contacting the carbon nanotube aggregates with graphene oxide, and forming the carbon nanotube aggregates in contact with the graphene oxide into a carbon nanotube fiber.

Abstract: The present invention relates to an optical fiber device for removing cladding light, an apparatus and a method for etching the same.

Abstract: Disclosed is a touch sensitive display apparatus which decreases a load of each of a plurality of touch electrodes and reduces a load deviation between the plurality of touch electrodes, thereby enhancing image quality. The touch sensitive display apparatus comprises a touch sensitive panel. The touch panel comprises a plurality of touch electrodes comprising at least a first touch electrode. The first touch electrode comprises a plurality of first touch electrode lines that are parallel to each other. A first touch signal line is connected to the plurality of first touch electrode lines of the first touch electrode, and the first touch electrode is driven for image display and touch sensing via the first touch signal line. A first connecting line is in a different layer than the first touch electrode lines, and the first connecting line is connected to the plurality of first touch electrode lines.

Abstract: A printed circuit board according to an embodiment comprises: a substrate comprising at least two insulating layers; pads arranged on the substrate; heat dissipation vias arranged to pass through the substrate in a region of the substrate which vertically overlaps the pads; and through vias arranged to pass through the substrate in a region of the substrate which does not vertically overlap the pads, wherein each heat dissipation via includes a plurality of via parts which are spaced apart from each other in at least one of the at least two insulating layers, the upper surface of each of the plurality of via parts has a first horizontal width in a first direction that is smaller than a second horizontal width thereof in a second direction different from the first direction, and the plurality of via parts have a surface area corresponding to 10% or greater of the surface area of the pads.

Abstract: Provided is a composition for the prevention and treatment of one or more cancers selected from the group consisting of breast cancer, liver cancer, and gastric cancer, the composition comprising selenopsammaplin A as active ingredients. The selenopsammaplin A and derivatives thereof of the present invention have been confirmed to exhibit excellent anticancer activity against breast cancer, liver cancer, and gastric cancer cells, and exhibit not only a strong effect of suppressing breast cancer growth compared to existing psammaplin A but also an excellent effect of suppressing the metastasis of breast cancer cells, and thus the selenopsammaplin A and derivatives thereof are expected to be effectively usable as a pharmaceutical composition for the prevention and treatment of breast cancer, liver cancer, and/or gastric cancer, and for the suppression of breast cancer metastasis.

Abstract: The present invention relates to a method and a system for selecting a drug customized on the basis of individual protein information by using individual genome sequences. The method and the system of the present invention can predict the individual side effects or danger of a certain drug by analyzing the sequence of the exon region of a gene encoding various proteins involved in the pharmacokinetics or pharmacodynamics of a predetermined drug or drug group, and have high reliability and are widely applicable and universal.

Abstract: A vehicle includes a boost converter configured to bypass or to convert a stack voltage and output the bypassed or converted stack voltage as a first voltage in response to a first control signal, a first switching unit configured to be switched in response to a first switching signal to form a main path to supply the first voltage to a battery, a buck converter configured to convert and output a level of the first voltage to the battery as a second voltage in response to a second control signal, a second switching unit configured to be switched in response to a second switching signal to form a bypass path to supply the second voltage to the battery, and a controller configured to inspect a level of voltage charged in the battery and generate the first and second control signals and the first and second switching signals based thereon.

Abstract: Disclosed are an apparatus and a method for providing security and an apparatus and a method for executing security to protect a code of a shared object.

Abstract: The present invention relates to: novel selenopsammaplin A and a derivative thereof, which have anticancer activity; a preparation method therefor; and a pharmaceutical composition containing the same as active ingredients and, more specifically, to: a novel compound selenopsammaplin A and a derivative thereof which exhibit more excellent anticancer activity since a disulfide moiety thereof is substituted with diselenide according to research on the structural activity of psammaplin A, which is known to have an effect of inhibiting the growth of cancer cells; a preparation method therefor; and a composition for preventing or treating cancer, containing the same as active ingredients. According to the present invention, the novel selenopsammaplin A and the derivative thereof exhibit excellent anticancer activity on various human cancer cell lines so as to be expected to be effectively usable in a pharmaceutical composition for cancer prevention and treatment.

Abstract: The present invention relates to a reactor for non-oxidative direct conversion of methane and a method of manufacturing ethylene and an aromatic compound using the same. More particularly, the present invention relates to a reactor for non-oxidative direct conversion of methane in which a catalytic reaction velocity is maximized, the production of coke is minimized, and a high conversion rate of methane and a high yield of ethylene and an aromatic compound are ensured when ethylene and the aromatic compound are manufactured from methane, and a method of manufacturing ethylene and an aromatic compound using the same.

Abstract: A semiconductor memory system including: a semiconductor memory device suitable for storing a codeword; and an LDPC decoder suitable for decoding the codeword to generate decoded data, wherein the LDPC decoder includes: a message passing decoding component suitable for performing a first decoding operation of decoding the codeword, and calculating the minimum value among numbers of UCNs; and an error path detection component suitable for detecting error path candidates using a tree in which each of UCNs corresponding to the minimum value is set to a root node, sorting the detected error path candidates in ascending order of maximum LLRs, resetting symbol values and LLRs of variable nodes in the error path candidates, and providing the message passing decoding unit with information on the reset symbol values and LLRs.

Abstract: A vehicle having a fuel cell includes a cell stack including a plurality of unit cells stacked on one another, a direct current/direct current (DC/DC) converter configured to convert the level of stack voltage output from the cell stack and including a discharger to remove residual energy thereof, a power distributor configured to distribute the level-converted voltage output from the DC/DC converter or to provide voltage remaining in the cell stack to the discharger to discharge the voltage in response to first control signals, and a controller configured to generate the first control signals depending on whether the vehicle is traveling normally.

Abstract: A nucleic acid sequence security method comprises the steps of: (a) creating a plurality of composites each comprising at least one of target elements derived from a nucleic acid sequence of an analysis requester or disguising elements identical to or different from the target elements; and (b) providing the created plurality of composites to an analyst.